Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Research

The global burden and risk factors of cardiovascular diseases in adolescent and young adults, 1990–2019

Authors: Zhuang Tong, Yingying Xie, Kaixiang Li, Ruixia Yuan, Liang Zhang

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

To provide details of the burden and the trend of the cardiovascular disease (CVD) and its risk factors in adolescent and young adults.

Methods

Age-standardized rates (ASRs) of incidence, mortality and Disability-Adjusted Life Years (DALYs) were used to describe the burden of CVD in adolescents and young adults. Estimated Annual Percentage Changes (EAPCs) of ASRs were used to describe the trend from 1990 to 2019. Risk factors were calculated by Population Attributable Fractions (PAFs).

Results

In 2019, the age-standardized incidence rate (ASIR), age-standardized mortality rate (ASMR) and age-standardized DALYs rate (ASDR) of CVD were 129.85 per 100 000 (95% Confidence interval (CI): 102.60, 160.31), 15.12 per 100 000 (95% CI: 13.89, 16.48) and 990.64 per 100 000 (95% CI: 911.06, 1076.46). The highest ASRs were seen in low sociodemographic index (SDI) and low-middle SDI regions. The burden was heavier in male and individuals aged 35–39. From 1990 to 2019, 72 (35.29%) countries showed an increasing trend of ASIR and more than 80% countries showed a downward trend in ASMR and ASDR. Rheumatic heart disease had the highest ASIR and Ischemic Heart Disease was the highest in both ASMR and ASDR. The main attributable risk factor for death and DALYs were high systolic blood pressure, high body-mass index and high LDL cholesterol.

Conclusions

The burden of CVD in adolescent and young adults is a significant global health challenge. It is crucial to take into account the disparities in SDI levels among countries, gender and age characteristics of the population, primary types of CVD, and the attributable risk factors when formulating and implementing prevention strategies.
Appendix
Available only for authorised users
Literature
1.
Mensah GA, Roth GA, Fuster V. The Global Burden of Cardiovascular diseases and Risk factors: 2020 and Beyond. J Am Coll Cardiol. 2019;74(20):2529–32.CrossRefPubMed
2.
Gooding H, Johnson HM. The unchartered Frontier: preventive cardiology between the ages of 15 and 35 years. Curr Cardiovasc Risk Rep 2016, 10.
3.
Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338(23):1650–6.
4.
Saeedi P, Shavandi A, Skidmore PML. What do we know about Diet and markers of Cardiovascular Health in children: a review. Int J Environ Res Public Health 2019, 16(4).
5.
Zilla P, Yacoub M, Zuhlke L, Beyersdorf F, Sliwa K, Khubulava G, Bouzid A, Mocumbi AO, Velayoudam D, Shetty D, et al. Global unmet needs in cardiac surgery. Glob Heart. 2018;13(4):293–303.CrossRefPubMed
6.
Rodgers JL, Jones J, Bolleddu SI, Vanthenapalli S, Rodgers LE, Shah K, Karia K, Panguluri SK. Cardiovascular risks Associated with gender and aging. J Cardiovasc Dev Dis 2019, 6(2).
7.
Miller KD, Fidler-Benaoudia M, Keegan TH, Hipp HS, Jemal A, Siegel RL. Cancer statistics for adolescents and young adults, 2020. CA Cancer J Clin. 2020;70(6):443–59.CrossRefPubMed
8.
Collaborators GBDAYAC. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the global burden of Disease Study 2019. Lancet Oncol. 2022;23(1):27–52.CrossRef
9.
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al. Global Burden of Cardiovascular diseases and Risk factors, 1990–2019: Update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021.CrossRefPubMedPubMedCentral
10.
Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.CrossRef
11.
Collaborators GBDRF. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1223–49.CrossRef
12.
Collaborators GBDD. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1160–203.CrossRef
13.
Zhang L, Tong Z, Han R, Guo R, Zang S, Zhang X, Yuan R, Yang Y. Global, Regional, and National burdens of Ischemic Heart Disease Attributable to Smoking from 1990 to 2019. J Am Heart Assoc. 2023;12(3):e028193.CrossRefPubMedPubMedCentral
14.
Global Burden of Disease, Cancer C, Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, Abdelalim A, Abdoli A, Abdollahpour I, et al. Global, Regional, and National Cancer incidence, mortality, years of Life Lost, Years lived with disability, and disability-adjusted life-years for 29 Cancer groups, 1990 to 2017: a systematic analysis for the global burden of Disease Study. JAMA Oncol. 2019;5(12):1749–68.CrossRef
15.
Hankey BF, Ries LA, Kosary CL, Feuer EJ, Merrill RM, Clegg LX, Edwards BK. Partitioning linear trends in age-adjusted rates. Cancer Causes Control. 2000;11(1):31–5.CrossRefPubMed
16.
Yuan R, Ren F, Xie Y, Li K, Tong Z. The Global, Regional, and National burdens of Cervical Cancer Attributable to Smoking from 1990 to 2019: Population-based study. JMIR Public Health Surveill. 2022;8(12):e40657.CrossRefPubMedPubMedCentral
17.
Charlson FJ, Moran AE, Freedman G, Norman RE, Stapelberg NJ, Baxter AJ, Vos T, Whiteford HA. The contribution of major depression to the global burden of ischemic heart disease: a comparative risk assessment. BMC Med. 2013;11:250.CrossRefPubMedPubMedCentral
18.
Yu Y, Arah OA, Liew Z, Cnattingius S, Olsen J, Sorensen HT, Qin G, Li J. Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up. BMJ. 2019;367:l6398.CrossRefPubMedPubMedCentral
19.
Caleyachetty R, Echouffo-Tcheugui JB, Tait CA, Schilsky S, Forrester T, Kengne AP. Prevalence of behavioural risk factors for cardiovascular disease in adolescents in low-income and middle-income countries: an individual participant data meta-analysis. Lancet Diabetes Endocrinol. 2015;3(7):535–44.CrossRefPubMed
20.
Laitinen TT, Pahkala K, Magnussen CG, Viikari JS, Oikonen M, Taittonen L, Mikkila V, Jokinen E, Hutri-Kahonen N, Laitinen T, et al. Ideal cardiovascular health in childhood and cardiometabolic outcomes in adulthood: the Cardiovascular Risk in Young finns Study. Circulation. 2012;125(16):1971–8.CrossRefPubMed
21.
Li Y, Cao GY, Jing WZ, Liu J, Liu M. Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990–2019: findings from 2019 global burden of disease study. Eur J Prev Cardiol. 2023;30(3):276–86.CrossRefPubMed
22.
Martinez-Garcia M, Gutierrez-Esparza GO, Roblero-Godinez JC, Marin-Perez DV, Montes-Ruiz CL, Vallejo M, Hernandez-Lemus E. Cardiovascular Risk factors and Social Development Index. Front Cardiovasc Med. 2021;8:631747.CrossRefPubMedPubMedCentral
23.
Remenyi B, Carapetis J, Wyber R, Taubert K, Mayosi BM, World Heart F. Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol. 2013;10(5):284–92.CrossRefPubMed
24.
Zhang L, Tong Z, Han R, Li K, Zhang X, Yuan R. Spatiotemporal trends in global burden of rheumatic heart disease and associated risk factors from 1990 to 2019. Int J Cardiol. 2023;384:100–6.CrossRefPubMed
25.
Sliwa K, Carrington MJ, Klug E, Opie L, Lee G, Ball J, Stewart S. Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: insights from the heart of Soweto Study. Heart. 2010;96(23):1878–82.CrossRefPubMed
26.
Yadgir S, Johnson CO, Aboyans V, Adebayo OM, Adedoyin RA, Afarideh M, Alahdab F, Alashi A, Alipour V, Arabloo J, et al. Global, Regional, and National Burden of Calcific Aortic Valve and degenerative mitral valve diseases, 1990–2017. Circulation. 2020;141(21):1670–80.CrossRefPubMed
27.
O’Neil A, Scovelle AJ, Milner AJ, Kavanagh A. Gender/Sex as a Social Determinant of Cardiovascular Risk. Circulation. 2018;137(8):854–64.CrossRefPubMed
28.
Damen JA, Hooft L, Schuit E, Debray TP, Collins GS, Tzoulaki I, Lassale CM, Siontis GC, Chiocchia V, Roberts C, et al. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ. 2016;353:i2416.CrossRefPubMedPubMedCentral
29.
Colafella KMM, Denton KM. Sex-specific differences in hypertension and associated cardiovascular disease. Nat Rev Nephrol. 2018;14(3):185–201.CrossRefPubMed
30.
Connelly PJ, Azizi Z, Alipour P, Delles C, Pilote L, Raparelli V. The importance of gender to Understand Sex differences in Cardiovascular Disease. Can J Cardiol. 2021;37(5):699–710.CrossRefPubMed
31.
32.
Khan SS, Ning H, Wilkins JT, Allen N, Carnethon M, Berry JD, Sweis RN, Lloyd-Jones DM. Association of Body Mass Index with Lifetime Risk of Cardiovascular Disease and Compression of Morbidity. JAMA Cardiol. 2018;3(4):280–7.CrossRefPubMedPubMedCentral
33.
Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, Invitti C, Litwin M, Mancia G, Pall D, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016;34(10):1887–920.CrossRefPubMed
34.
35.
Collaboration NCDRF. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–42.CrossRef
Metadata
Title
The global burden and risk factors of cardiovascular diseases in adolescent and young adults, 1990–2019
Authors
Zhuang Tong
Yingying Xie
Kaixiang Li
Ruixia Yuan
Liang Zhang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18445-6

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue

Research

Objectively measured the impact of ambient air pollution on physical activity for older adults

Research

Exploring barriers of health literacy on non-communicable disease prevention and care among patients in north wollo zone public hospitals; Northeast, Ethiopia, 2023: application of socio-ecological model

Research

Depressive symptoms, parenting attitude, and violent discipline among caregivers of left-behind children in rural China: a cross-sectional study

Research

Is occupational noise associated with arthritis? Cross-sectional evidence from US population

Research

Mobile device screen time is associated with poorer language development among toddlers: results from a large-scale survey

Research

The contribution and interplay of implicit and explicit processes on physical activity behavior: empirical testing of the physical activity adoption and maintenance (PAAM) model